Literature DB >> 15862188

X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype.

Joanne H Gibson1, Sarah L Williamson, Susan Arbuckle, John Christodoulou.   

Abstract

Skewed X chromosome inactivation (XCI) has been implicated in modulating the severity of Rett syndrome (RTT), although studies by different groups have yielded conflicting results. In this study we have characterised the XCI pattern in various neuroanatomical regions of nine RTT brains and non-neural tissue in two of these patients to determine whether or not variable XCI patterns occur in different brain regions or somatic tissues of the same patient. The mean XCI patterns for frontal and occipital cortex were compared between RTT and control subjects, and showed no significant differences when comparing RTT frontal to control frontal cortex or RTT occipital to control occipital cortex. However, one RTT subject displayed variability across the different neuroanatomical regions of the brain and skewing in some non-neural tissues. This observation adds another dimension to the epigenetic factors that may contribute to the phenotype in RTT. It also mandates that caution should be exercised in factoring XCI, including assumptions based on the blood XCI pattern, into the development of phenotype-genotype correlations.

Entities:  

Mesh:

Year:  2005        PMID: 15862188     DOI: 10.1016/j.braindev.2004.07.002

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  15 in total

1.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

2.  Brief report: MECP2 mutations in people without Rett syndrome.

Authors:  Bernhard Suter; Diane Treadwell-Deering; Huda Y Zoghbi; Daniel G Glaze; Jeffrey L Neul
Journal:  J Autism Dev Disord       Date:  2014-03

3.  Genes known to escape X chromosome inactivation predict co-morbid chronic musculoskeletal pain and posttraumatic stress symptom development in women following trauma exposure.

Authors:  Shan Yu; Constance Chen; Yue Pan; Michael C Kurz; Elizabeth Datner; Phyllis L Hendry; Marc-Anthony Velilla; Christopher Lewandowski; Claire Pearson; Robert Domeier; Samuel A McLean; Sarah D Linnstaedt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-11       Impact factor: 3.568

4.  Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review

Authors:  Jatinder Singh; Evamaria Lanzarini; Paramala Santosh
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

Review 5.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

6.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.

Authors:  Vishnu Anand Cuddapah; Rajesh B Pillai; Kiran V Shekar; Jane B Lane; Kathleen J Motil; Steven A Skinner; Daniel Charles Tarquinio; Daniel G Glaze; Gerald McGwin; Walter E Kaufmann; Alan K Percy; Jeffrey L Neul; Michelle L Olsen
Journal:  J Med Genet       Date:  2014-01-07       Impact factor: 6.318

7.  ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticity.

Authors:  Hiromi Hirata; Indrajit Nanda; Anne van Riesen; Gai McMichael; Hao Hu; Melanie Hambrock; Marie-Amélie Papon; Ute Fischer; Sylviane Marouillat; Can Ding; Servane Alirol; Melanie Bienek; Sabine Preisler-Adams; Astrid Grimme; Dominik Seelow; Richard Webster; Eric Haan; Alastair MacLennan; Werner Stenzel; Tzu Ying Yap; Alison Gardner; Lam Son Nguyen; Marie Shaw; Nicolas Lebrun; Stefan A Haas; Wolfram Kress; Thomas Haaf; Elke Schellenberger; Jamel Chelly; Géraldine Viot; Lisa G Shaffer; Jill A Rosenfeld; Nancy Kramer; Rena Falk; Dima El-Khechen; Luis F Escobar; Raoul Hennekam; Peter Wieacker; Christoph Hübner; Hans-Hilger Ropers; Jozef Gecz; Markus Schuelke; Frédéric Laumonnier; Vera M Kalscheuer
Journal:  Am J Hum Genet       Date:  2013-04-25       Impact factor: 11.025

8.  Monoallelic expression of the human FOXP2 speech gene.

Authors:  Abidemi A Adegbola; Gerald F Cox; Elizabeth M Bradshaw; David A Hafler; Alexander Gimelbrant; Andrew Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

9.  Investigation of modifier genes within copy number variations in Rett syndrome.

Authors:  Rosangela Artuso; Filomena T Papa; Elisa Grillo; Mafalda Mucciolo; Dag H Yasui; Keith W Dunaway; Vittoria Disciglio; Maria A Mencarelli; Marzia Pollazzon; Michele Zappella; Giuseppe Hayek; Francesca Mari; Alessandra Renieri; Janine M Lasalle; Francesca Ariani
Journal:  J Hum Genet       Date:  2011-05-19       Impact factor: 3.172

10.  Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies.

Authors:  K Laurence Jost; Andrea Rottach; Manuela Milden; Bianca Bertulat; Annette Becker; Patricia Wolf; Juan Sandoval; Paolo Petazzi; Dori Huertas; Manel Esteller; Elisabeth Kremmer; Heinrich Leonhardt; M Cristina Cardoso
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.